세계의 분무건조 생물제제 시장 보고서(2025년)

Spray-dried biologics are biologic drugs that have been converted from a liquid formulation into a dry powder through a rapid drying method. In this process, the liquid is sprayed into heated air, allowing moisture to evaporate quickly while preserving the integrity of sensitive components such as proteins, vaccines, or enzymes. The resulting dry powder provides benefits such as improved stability, easier handling, and suitability for various delivery routes.

The main product types of spray-dried biologics include monoclonal antibodies, vaccines, enzymes, hormones, and others. Monoclonal antibodies are laboratory-developed molecules that are engineered to identify and bind to a specific target antigen with high accuracy. The different routes of administration include oral, inhalation or pulmonary, injectable, and topical, and these products serve end users such as hospitals, research institutes, pharmaceutical and biotechnology companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The spray-dried biologics market research report is one of a series of new reports from The Business Research Company that provides spray-dried biologics market statistics, including the spray-dried biologics industry global market size, regional shares, competitors with the spray-dried biologics market share, detailed spray-dried biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the spray-dried biologics industry. This spray-dried biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The spray-dried biologics market size has grown rapidly in recent years. It will grow from $1.66 billion in 2024 to $1.86 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period resulted from increasing outsourcing of biomanufacturing activities, rising demand for stable high-value biologic formulations, growing focus on extending the shelf life of complex therapeutics, a surge in global biologics production volumes, expansion of contract development and manufacturing activities, and increasing commercialization of temperature-sensitive biologic drugs.

The spray-dried biologics market size is expected to see rapid growth in the next few years. It will grow to $2.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period will be driven by growing demand for long-term room-temperature-stable biologics, rising investment in large-scale biologics manufacturing worldwide, increasing adoption of outsourced formulation and processing services, a surge in the development of novel biologic drug classes that require robust stabilization, expansion of biologics pipelines across emerging markets, and increasing emphasis on supply-chain efficiency and reduced cold-chain dependence. Major trends in the forecast period include technological advancements in particle engineering platforms, progress in continuous spray-drying systems for biologics, innovations in high-precision droplet and drying control technologies, developments in hybrid drying and encapsulation methods, research and development in excipient systems designed for biologic stabilization, and innovations in integrated fill-finish and dry-powder handling solutions.

The growing demand for biopharmaceuticals is expected to drive the expansion of the spray-dried biologics market in the coming years. Biopharmaceuticals are therapeutic products derived from biological sources, including living cells, proteins, and other biomolecules. This demand is increasing due to the global rise in chronic and complex health conditions, which has created a need for therapies that provide higher specificity, improved efficacy, and fewer systemic side effects. The spray-dried biologics sector is seeing heightened interest as the rapid growth of biopharmaceuticals encourages companies to adopt scalable formulation technologies that enhance stability, shelf life, and delivery efficiency. For example, in February 2025, the World Health Organization (WHO), a Switzerland-based international public health agency, reported that the 2023 WHO Essential Medicines List included 81 biologic therapies, representing more than 15% of all essential medicines. Consequently, the rising demand for biopharmaceuticals is driving the growth of the spray-dried biologics market.

Key players in the spray-dried biologics market are focusing on integrating technological innovations such as drum dosing technology to improve dose accuracy, powder handling efficiency, and reliable large-scale capsule filling. Drum dosing technology is an advanced powder-filling method that uses a rotating drum with precision-engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules. This approach enables consistent low-dose filling, better flow management of spray-dried powders, and high-throughput scalability. For instance, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), upgraded its inhalation manufacturing facility in the US with potent capsule-filling capabilities using drum-based dosing systems and in-line advanced mass verification. This upgraded platform supports precise filling of engineered and spray-dried powders, featuring real-time dose validation and controlled low-humidity processing, thereby enhancing manufacturing efficiency, product consistency, and readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

In May 2023, Hovione, a Portugal-based integrated CDMO specializing in spray drying and particle engineering, partnered with H&T Presspart to advance high-efficiency device technology for dry powder inhalation delivery. This collaboration aims to strengthen Hovione's capabilities in engineered spray-dried and high-dose inhalation formulations by leveraging Presspart's Sunriser capsule-based dry powder inhaler platform to improve the performance and commercial readiness of inhalation therapies. H&T Presspart, based in Germany, specializes in drug-delivery devices and inhalation technology.

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BUCHI Labortechnik AG.

North America was the largest region in the spray-dried biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spray-dried biologics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spray-dried biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spray-dried biologics market consists of sales of peptide therapeutics, deoxyribonucleic acid vaccines, ribonucleic acid vaccines, nanobodies, antibody-drug conjugates, and recombinant proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spray-Dried Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spray-dried biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spray-dried biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spray-dried biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Monoclonal Antibodies; Vaccines; Enzymes; Hormones; Other Product Types
• 2) By Route Of Administration: Oral; Inhalation Or Pulmonary; Injectable; Topical
• 3) By End-User: Hospitals; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Monoclonal Antibodies: Chimeric Antibodies; Humanized Antibodies; Fully Human Antibodies; Bispecific Antibodies; Antibody Fragments
• 2) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Viral Vector Vaccines; Recombinant Protein Vaccines
• 3) By Enzymes: Therapeutic Enzymes; Digestive Enzymes; Metabolic Enzymes; Recombinant Enzymes; Replacement Enzymes
• 4) By Hormones: Peptide Hormones; Protein Hormones; Steroid Hormones; Recombinant Hormones; Growth Hormones
• 5) By Other Product Types: Blood Factors; Cytokines; Fusion Proteins; Nucleic Acid Therapeutics; Cell Culture Media Proteins
• Companies Mentioned: Thermo Fisher Scientific Inc.; Evonik Industries AG; Lonza Group AG; GEA Group; Fareva Group; Almac Group Limited; Seqens Group; Fabbrica Italiana Sintetici S.p.A.; CordenPharma International; Hovione FarmaCiencia SA; Veranova Inc.; Pace Analytical Services LLC; Olon S.p.A.; Nova Laboratories Ltd; Leukocare AG; Micro Sphere SA; Seran Bioscience LLC; CritiTech Particle Engineering Solutions LLC; Xedev BV; BUCHI Labortechnik AG.
• Countries:

Table of Contents

1. Executive Summary

2. Spray-Dried Biologics Market Characteristics

3. Spray-Dried Biologics Market Trends And Strategies

4. Spray-Dried Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Spray-Dried Biologics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Spray-Dried Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Spray-Dried Biologics Market Growth Rate Analysis
• 5.4. Global Spray-Dried Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Spray-Dried Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Spray-Dried Biologics Total Addressable Market (TAM)

6. Spray-Dried Biologics Market Segmentation

• 6.1. Global Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Vaccines
• Enzymes
• Hormones
• Other Product Types
• 6.2. Global Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Inhalation Or Pulmonary
• Injectable
• Topical
• 6.3. Global Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End-Users
• 6.4. Global Spray-Dried Biologics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chimeric Antibodies
• Humanized Antibodies
• Fully Human Antibodies
• Bispecific Antibodies
• Antibody Fragments
• 6.5. Global Spray-Dried Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Viral Vector Vaccines
• Recombinant Protein Vaccines
• 6.6. Global Spray-Dried Biologics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Enzymes
• Digestive Enzymes
• Metabolic Enzymes
• Recombinant Enzymes
• Replacement Enzymes
• 6.7. Global Spray-Dried Biologics Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peptide Hormones
• Protein Hormones
• Steroid Hormones
• Recombinant Hormones
• Growth Hormones
• 6.8. Global Spray-Dried Biologics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Factors
• Cytokines
• Fusion Proteins
• Nucleic Acid Therapeutics
• Cell Culture Media Proteins

7. Spray-Dried Biologics Market Regional And Country Analysis

• 7.1. Global Spray-Dried Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Spray-Dried Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spray-Dried Biologics Market

• 8.1. Asia-Pacific Spray-Dried Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spray-Dried Biologics Market

• 9.1. China Spray-Dried Biologics Market Overview
• 9.2. China Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spray-Dried Biologics Market

• 10.1. India Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spray-Dried Biologics Market

• 11.1. Japan Spray-Dried Biologics Market Overview
• 11.2. Japan Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spray-Dried Biologics Market

• 12.1. Australia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spray-Dried Biologics Market

• 13.1. Indonesia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spray-Dried Biologics Market

• 14.1. South Korea Spray-Dried Biologics Market Overview
• 14.2. South Korea Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spray-Dried Biologics Market

• 15.1. Western Europe Spray-Dried Biologics Market Overview
• 15.2. Western Europe Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spray-Dried Biologics Market

• 16.1. UK Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spray-Dried Biologics Market

• 17.1. Germany Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spray-Dried Biologics Market

• 18.1. France Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spray-Dried Biologics Market

• 19.1. Italy Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spray-Dried Biologics Market

• 20.1. Spain Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spray-Dried Biologics Market

• 21.1. Eastern Europe Spray-Dried Biologics Market Overview
• 21.2. Eastern Europe Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spray-Dried Biologics Market

• 22.1. Russia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spray-Dried Biologics Market

• 23.1. North America Spray-Dried Biologics Market Overview
• 23.2. North America Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spray-Dried Biologics Market

• 24.1. USA Spray-Dried Biologics Market Overview
• 24.2. USA Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spray-Dried Biologics Market

• 25.1. Canada Spray-Dried Biologics Market Overview
• 25.2. Canada Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spray-Dried Biologics Market

• 26.1. South America Spray-Dried Biologics Market Overview
• 26.2. South America Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spray-Dried Biologics Market

• 27.1. Brazil Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spray-Dried Biologics Market

• 28.1. Middle East Spray-Dried Biologics Market Overview
• 28.2. Middle East Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spray-Dried Biologics Market

• 29.1. Africa Spray-Dried Biologics Market Overview
• 29.2. Africa Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spray-Dried Biologics Market Competitive Landscape And Company Profiles

• 30.1. Spray-Dried Biologics Market Competitive Landscape
• 30.2. Spray-Dried Biologics Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GEA Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fareva Group Overview, Products and Services, Strategy and Financial Analysis

31. Spray-Dried Biologics Market Other Major And Innovative Companies

• 31.1. Almac Group Limited
• 31.2. Seqens Group
• 31.3. Fabbrica Italiana Sintetici S.p.A.
• 31.4. CordenPharma International
• 31.5. Hovione FarmaCiencia SA
• 31.6. Veranova Inc.
• 31.7. Pace Analytical Services LLC
• 31.8. Olon S.p.A.
• 31.9. Nova Laboratories Ltd
• 31.10. Leukocare AG
• 31.11. Micro Sphere SA
• 31.12. Seran Bioscience LLC
• 31.13. CritiTech Particle Engineering Solutions LLC
• 31.14. Xedev BV
• 31.15. BUCHI Labortechnik AG

32. Global Spray-Dried Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spray-Dried Biologics Market

34. Recent Developments In The Spray-Dried Biologics Market

35. Spray-Dried Biologics Market High Potential Countries, Segments and Strategies

• 35.1 Spray-Dried Biologics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Spray-Dried Biologics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Spray-Dried Biologics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer